Incidence and predictors for cardiovascular events in patients with psoriatic arthritis

被引:85
|
作者
Eder, Lihi [1 ]
Wu, Ying [2 ]
Chandran, Vinod [1 ]
Cook, Richard [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Psoriatic Arthritis; Epidemiology; Atherosclerosis; Cardiovascular Disease; ATHEROSCLEROSIS RISK-FACTORS; POPULATION-BASED COHORT; RHEUMATOID-ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; FRAMINGHAM RISK; DISEASE; INFLAMMATION; METAANALYSIS; PREVALENCE; INDIVIDUALS;
D O I
10.1136/annrheumdis-2015-207980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the incidence and risk factors of cardiovascular events in patients with psoriatic arthritis (PsA). Methods A cohort analysis was conducted involving patients recruited and followed over the period from 1978 to 2013 in a large PsA clinic. The participants were assessed at 6 to 12-month intervals according to a standard protocol. The collected information included demographics, lifestyle habits, medical history, medications use and PsA-related outcomes. The primary outcome was a composite major cardiovascular end point comprising myocardial infarction, ischaemic stroke, revascularisation or cardiovascular death. The association between the features of disease activity and the occurrence of cardiovascular events was assessed using Cox proportional hazard models. Results A total of 1091 patients with PsA were analysed. During the follow-up period, 104 cardiovascular events occurred. A considerable proportion of patients developed a cardiovascular event (19.8% of the patients by the age of 70 years and 30.1% of patient by the age of 80 years). No trend in the risk of developing cardiovascular events was observed over the decades from 1978 to 2013 (p=0.73). In multivariate analysis, the following variables were independent predictors of major cardiovascular events: hypertension (relative risk (RR) 1.81, p=0.015), diabetes (RR 2.72, p<0.001) and the number of dactylitic digits (RR 1.20, p<0.001). Sedimentation rate was a significant predictor only among women (RR 1.83, p=0.02). Conclusion A significant proportion of patients with PsA develop cardiovascular events during the course of their disease. Increased cardiovascular risk is associated with a combination of traditional cardiovascular risk factors and disease activity.
引用
收藏
页码:1680 / 1686
页数:7
相关论文
共 50 条
  • [31] Prevalence of cardiovascular risk factors in patients with psoriatic arthritis
    Khraishi, Majed
    Aslanov, Rana
    Rampakakis, Emmanouil
    Pollock, Clare
    Sampalis, John S.
    CLINICAL RHEUMATOLOGY, 2014, 33 (10) : 1495 - 1500
  • [32] Cardiovascular Diseases in the Patients With Psoriatic Arthritis
    Akhlaq, Anum
    Ali, Huma Fatima
    Sheikh, Abu Baker
    Muhammad, Hafiz
    Ijaz, Sardar Hassan
    Sattar, Muhammad Hassaan
    Nazir, Salik
    Din, Mian Tanveer Ud
    Nasir, Usama
    Khan, Muhammad Zia
    Muslim, Muhammad Osama
    Wazir, Muhammad Hisham Khan
    Dani, Sourbha S.
    Fudim, Marat
    Minhas, Abdul Mannan Khan
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (06)
  • [33] Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
    Peluso, Rosario
    Caso, Francesco
    Tasso, Marco
    Ambrosino, Pasquale
    Di Minno, Matteo Nicola Dario
    Lupoli, Roberta
    Criscuolo, Livio
    Caso, Paolo
    Ursini, Francesco
    Del Puente, Antonio
    Scarpa, Raffaele
    Costa, Luisa
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (03) : 199 - 209
  • [34] Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
    Nas, Kemal
    Karkucak, Murat
    Durmus, Bekir
    Karatay, Saliha
    Capkin, Erhan
    Kaya, Arzu
    Ucmak, Derya
    Akar, Zeynel Abidin
    Cevik, Remzi
    Kilic, Erkan
    Kilic, Gamze
    Ozgocmen, Salih
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (08) : 873 - 879
  • [35] Incidence and Clinical Predictors of Psoriatic Arthritis in Patients With Psoriasis: A Population-Based Study
    Wilson, Floranne C.
    Icen, Murat
    Crowson, Cynthia S.
    Mcevoy, Marian T.
    Gabriel, Sherine E.
    Kremers, Hilal Maradit
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (02): : 233 - 239
  • [36] Prevalence and Incidence of Psoriatic Arthritis among Patients with Psoriasis and Risk Factors for Psoriatic Arthritis in Republic of Korea: A Nationwide Database Cohort Study
    Bang, Chul Hwan
    Kim, Yoon-Seob
    An, Jihye
    Jung, Eun Suk
    Ahn, Jiyoon
    Kim, Jung-Ae
    Park, Chul Jong
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [37] Asymptomatic Hyperuricemia and Serum Uric Acid Concentration Correlate with Subclinical Atherosclerosis in Psoriatic Arthritis Patients Without Clinically Evident Cardiovascular Disease
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    Vazquez-Rodriguez, Tomas R.
    Gomez-Acebo, Ines
    Miranda-Filloy, Jose A.
    Paz-Carreira, Jose
    Martin, Javier
    Llorca, Javier
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 39 (03) : 157 - 162
  • [38] High incidence of cardiovascular events in patients with rheumatoid arthritis
    Steen, K. S. S.
    Lems, W. F.
    Visman, I. M.
    Heierman, M.
    Dijkmans, B. A. C.
    Twisk, J. W. R.
    Boers, M.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (09) : 1509 - 1510
  • [39] Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
    Degboe, Yannick
    Koch, Richard
    Zabraniecki, Laurent
    Jamard, Benedicte
    Couture, Guillaume
    Ruidavets, Jean Bernard
    Ferrieres, Jean
    Ruyssen-Witrand, Adeline
    Constantin, Arnaud
    FRONTIERS IN MEDICINE, 2022, 9
  • [40] Cardiovascular comorbidities in psoriatic arthritis: state of the art
    Dey, Mrinalini
    Nikiphorou, Elena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2024, 16